Self-management of oral anticoagulation with low- or conventional-intensity INR did not differ for thromboembolism prevention

Schellong, Sebastian M.
March 2008
ACP Journal Club;Mar/Apr2008, Vol. 148 Issue 2, p20
Academic Journal
The article focuses on the randomized controlled trial (RCT) investigating if self management of oral anticoagulation with a low-intensity target international normalized ratio (INR) reduces thromboembolic events in patients with mechanical heart valves. The trial, conducted with 2673 patients (18 years of age) found out that self management of oral anticoagulation with low- or conventional-intensity INR did not differ for thromboembolism prevention.


Related Articles

  • FOREWORD. Kakkar, Vijay V. // Drugs;2010 Supplement 2, Vol. 70, p1 

    A foreword to the December 14, 2010 issue of the journal "Drugs" is presented.

  • dipyridamole.  // Davis's Drug Guide for Nurses, 10th edition;2007, p403 

    The article presents a nursing guide to dipyridamole, an antiplatelet and diagnostic agent for the prevention of thromboembolism in patients with prosthetic heart valves, among others. Its mechanism of action and pharmacokinetics are explained. Contraindications for the drug are presented. Its...

  • Edoxaban Tosylate.  // American Journal of Cardiovascular Drugs;2011, Vol. 11 Issue 2, p129 

    Daiichi Sankyo is developing edoxaban tosylate (DU 176b; DU-176; DU-176b; DU176b) as an orally active direct factor Xa inhibitor for the prevention of stroke and the prevention and treatment of venous thromboembolism. Two dosing regimens of edoxaban tosylate are being compared with warfarin over...

  • Prolonged Versus Standard-Duration Venous Thromboprophylaxis in Major Orthopedic Surgery. Sobieraj, Diana M.; Lee, Soyon; Coleman, Craig I.; Tongbram, Vanita; Chen, Wendy; Colby, Jennifer; Kluger, Jeffrey; Makanji, Sagar; Ashaye, Ajibade O.; White, C. Michael // Annals of Internal Medicine;5/15/2012, Vol. 156 Issue 10, p720 

    Background: The optimal duration of thromboprophylaxis after major orthopedic surgery is unclear. Purpose: To compare the benefits and harms of prolonged versus standard-duration thromboprophylaxis after major orthopedic surgery in adults. Data Sources: Cochrane Central Register of Controlled...

  • Massive pulmonary embolism in a patient with Streptococcus agalactiae tricuspid valve endocarditis. Andresen, K.; Balf, D.; Marcu, C. B. // Heart;Mar2005, Vol. 91 Issue 3, p280 

    The article presents a medical case of massive pulmonary embolism in a patient with streptococcus agalactiae tricuspid valve endocarditis. The diagnosis of tricuspid valve endocarditis was confirmed when streptococcus agalactiae grew in three out of four admission peripheral blood samples....

  • Patent foramen ovale and the risk of stroke: smoking gun guilty by association? Amarenco, P. // Heart;Apr2005, Vol. 91 Issue 4, p441 

    This article presents information related to the relationship between patent foramen ovale and the risk of stroke. Between 15-20% of cases of brain infarction involve patients under the age of 55 years-that is, 150000 to 200000 patients each year in Europe. The main causes include cardiac valve...

  • Apixaban.  // AHFS Consumer Medication Information;Apr2018, p1 

    Apixaban is used help prevent strokes or blood clots in people who have atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes) that is not caused by heart valve disease. Apixaban is in a class of...

  • 2011 - Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes. Grubina, Rozalina; Smith, Steven A. // ACP Journal Club;5/15/2011, Vol. 154 Issue 5, p1 

    Question In patients with type 2 diabetes who are at high cardiovascular (CV) risk, what are the long-term CV effects of intensive compared with standard glucose control? Methods Design Randomized controlled trial (Action to Control Cardiovascular Risk in Diabetes [ACCORD] study)....

  • 2011 - Apixaban reduced stroke and systemic embolism compared with warfarin in atrial fibrillation. Klein, Liviu // ACP Journal Club;1/17/2012, Vol. 156 Issue 1, p1 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics